Skip to content

Active ingredient

Lubiprostone

43 finished FDA listings contain Lubiprostone as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
LUBIPROSTONE
Dosage forms
Capsule, Capsule, Gelatin Coated
Routes
Oral
Manufacturers / labelers
19
Strengths listed
.008 mg/1 · .024 mg/1 · 24 ug/1 · 8 ug/1
Brand names in FDA listings
Amitiza, Amitza

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 623033

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021908SUCAMPO PHARMA LLC2006-01-3125
ANDA 209450AMNEAL2021-11-302
ANDA 209920TEVA PHARMS USA INC2022-01-186
ANDA 214131ZYDUS PHARMS2023-03-236
ANDA 218640ASCENT PHARMS INC2025-01-024

Official labeling on DailyMed

Showing the 12 most recent of 25 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.